from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0011c/-

LFCtreatmentdescriptionclass of inhibitor

1.530

Amikacinug/mL Amikacintranslation

2.604

Cap5-10ug/mL Capreomycintranslation

1.425

Rox10-50 ug/mL Roxithromycintranslation

0.848

SM2-5 ug/mL Streptomycintranslation

0.559

Tet5-10 ug/mL Tetracyclinetranslation

-1.878

Rif0.2-5ug/mL Rifampicintranscription

-0.412

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.479

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.213

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.781

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.463

Clofazimine10-13 ug/mL Clofaziminerespiration

0.041

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.485

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.344

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.695

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.189

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.204

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.417

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.113

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.365

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.992

KCN5-20 ug/mL Potassium cyaniderespiration

-0.277

NaN30.2-2 mM Sodium aziderespiration

1.199

Nigericin50 uM Nigericinrespiration

-0.767

TRC10-150 ug/mL Triclosanrespiration

-1.122

TRZ10-25 ug/mL Thioridazinerespiration

1.866

Valinomycin0.5-10 uM Valinomycinrespiration

0.814

ZnSO42 mM ZnSO4respiration

1.005

menadione6-10 ug/mL Menadionerespiration

0.111

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.611

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.032

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.276

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.239

NRP_1Non-replicating persistence stage 1dosRassociated

0.259

Amp0.2mg/mL AmpicillincellWall

-0.455

Cephalexin20-100 ug/mL CephalexincellWall

0.805

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.035

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.384

EMB10-20 ug/mL EthambutolcellWall

0.078

Eta12-40 ug/mL EthionamidecellWall

0.285

INH0.2-0.4 ug/mL IsoniazidcellWall

0.182

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.165

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.401

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.721

BZA0.12 mg/mL BenzamidearomaticAmides

-0.433

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.093

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.531

H2O24 mM hydrogen peroxideDNAdamaging

-0.104

Levo10 ug/mL LevofloxacinDNAdamaging

0.499

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.227

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.099

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.430

UVUV-irradiationDNAdamaging

-0.675

ARP41-4 ug/mL Antitubercular compound ARP4?

0.092

Antimycin12.5-50 ug/mL Antimycin A?

-0.024

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.036

PA_110-50 ug/mL Antitubercular compound PA-1?

0.286

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.485

PA8240.2-2 ug/mL PA-824?

-0.206

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.057

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.950

Verapamil50 uM Verapamil?

-0.289

mercaptoethanol2 mM 2-Mercaptoethanol?

0.416

methoxatin10-20 ug/mL Methoxatin?